Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medical Ikkou Group Co., Ltd. (3353) Stock Price & Analysis

1 Followers

3353 Stock Chart & Stats

¥2,653.00-¥101.00(-3.67%)
At close: 3:30 PM GMT+9
¥2.7K¥2.8K¥2.9KAug 10Aug 24Sep 7Sep 18Oct 5Oct 19Nov 2
Day’s Range
JPY 2,627.00 - JPY 2,719.00
52-Week Range
JPY 2,590.00 - JPY 3,235.00
Previous Close
JPY 2,754.00
Volume
N/A
Average Volume (3M)
1,797
Market Cap
JPY 9.17B
Enterprise Value
JPY 13.22B
Total Cash (Recent Filing)
JPY 6.12B
Total Debt (Recent Filing)
JPY 10.36B
Price to Earnings (P/E)
7.0
Beta
0.28
Next Earnings
Jan 13, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
Feb 25, 2027
Dividend Yield
4.52%

Bulls Say, Bears Say

Bulls Say

Improving Revenue Growth

Revenue growth accelerated materially across the reported periods, indicating stronger top-line momentum than in 2023. Continued expansion can improve dispensing-pharmacy network utilization, support operating scale, and provide a durable base for earnings growth over the next several quarters.

Declining Leverage

The sustained reduction in debt-to-equity strengthens financial resilience and gives the company greater flexibility. Lower leverage can reduce balance-sheet risk, preserve borrowing capacity, and leave more room to fund pharmacy operations or other growth initiatives through changing conditions.

Positive Free Cash Flow

Positive free cash flow in every reported year demonstrates that the business has generated cash after investment rather than relying solely on accounting earnings. Although conversion is inconsistent, this recurring positive result provides an underlying funding source for operations and capital needs.

Bears Say

Weak Cash Conversion

Very weak cash conversion in the latest year reduces confidence in the durability of reported profits. If operating cash flow continues to lag earnings, working-capital demands or investment needs could constrain internally funded growth and make financial performance more volatile.

Margin Compression

The decline in EBITDA margin despite revenue growth indicates that incremental sales are not translating into comparable operating profitability. Persistent cost pressure or an unfavorable mix could limit earnings expansion and reduce the benefit of future revenue growth.

Modest Returns On Equity

Stable but modest returns on equity suggest the company is profitable without generating especially strong returns from its capital base. This can limit the pace at which retained earnings compound and indicates that operational improvements may be needed to lift long-term value creation.

3353 FAQ

What was Medical Ikkou Group Co., Ltd.’s price range in the past 12 months?
Medical Ikkou Group Co., Ltd. lowest stock price was ¥2590.00 and its highest was ¥3235.00 in the past 12 months.
What is Medical Ikkou Group Co., Ltd.’s market cap?
Medical Ikkou Group Co., Ltd.’s market cap is ¥9.17B.
When is Medical Ikkou Group Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medical Ikkou Group Co., Ltd.’s earnings last quarter?
Medical Ikkou Group Co., Ltd. released its earnings results on Oct 09, 2026. The company reported ¥56.44 earnings per share for the quarter.
Is Medical Ikkou Group Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Medical Ikkou Group Co., Ltd. pay dividends?
Medical Ikkou Group Co., Ltd. pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 4.52%. See more information on Medical Ikkou Group Co., Ltd. dividends here
What is Medical Ikkou Group Co., Ltd.’s EPS estimate?
Medical Ikkou Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical Ikkou Group Co., Ltd. have?
Medical Ikkou Group Co., Ltd. has 3,770,000 shares outstanding.
What happened to Medical Ikkou Group Co., Ltd.’s price movement after its last earnings report?
Medical Ikkou Group Co., Ltd. reported an EPS of ¥56.44 in its last earnings report. Following the earnings report the stock price went up 0.036%.
Which hedge fund is a major shareholder of Medical Ikkou Group Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3353
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology